TMC Life Sciences Bhd. Statistics
TMC Life Sciences Bhd. (0101) Stock Statistics & Valuation Metrics
Total Valuation
TMC Life Sciences Bhd. has a market cap or net worth of MYR 731.59M. The enterprise value is MYR 817.42M.
- Market Cap
- MYR 731.59M
- Enterprise Value
- MYR 817.42M
Share Statistics
TMC Life Sciences Bhd. has 1,741,882,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,741,882,300
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
TMC Life Sciences Bhd.’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 1.78%.
- Return on Equity (ROE)
- 0.02
- Return on Assets (ROA)
- 0.02
- Return on Invested Capital (ROIC)
- 1.78%
- Return on Capital Employed (ROCE)
- 0.03
- Revenue Per Employee
- 322.95K
- Profits Per Employee
- 14.28K
- Employee Count
- 1,217
- Asset Turnover
- 0.35
- Inventory Turnover
- 14.30
Valuation Ratios
The current PE Ratio of TMC Life Sciences Bhd. is 42.00. TMC Life Sciences Bhd.’s PEG ratio is 0.23.
- PE Ratio
- 42.00
- PS Ratio
- 1.86
- PB Ratio
- 0.84
- Price to FCF
- 16.41
- Price to Operating Cash Flow
- 12.37
- PEG Ratio
- 0.23
Income Statement
In the last 12 months, TMC Life Sciences Bhd. had revenue of 393.03M and earned 17.38M in profits. Earnings per share was 0.01.
- Revenue
- 393.03M
- Gross Profit
- 99.19M
- Operating Income
- 27.61M
- Pretax Income
- 25.73M
- Net Income
- 17.38M
- EBITDA
- 64.92M
- Earnings Per Share (EPS)
- 0.01
Cash Flow
In the last 12 months, operating cash flow was 59.12M and capital expenditures -14.55M, giving a free cash flow of 44.57M billion.
- Operating Cash Flow
- 59.12M
- Free Cash Flow
- 44.57M
- Free Cash Flow per Share
- 0.03
Dividends & Yields
TMC Life Sciences Bhd. pays an annual dividend of ―, resulting in a dividend yield of 0.44%
- Dividend Per Share
- ―
- Dividend Yield
- 0.44%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 6.09%
- Earnings Yield
- 2.38%
Stock Price Statistics
- Beta
- 0.79
- 52-Week Price Change
- -1.18%
- 50-Day Moving Average
- 0.42
- 200-Day Moving Average
- 0.47
- Relative Strength Index (RSI)
- 50.02
- Average Volume (3m)
- 90.07K
Important Dates
TMC Life Sciences Bhd. upcoming earnings date is Nov 18, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 14, 2026
- Next Earnings Date
- Nov 18, 2026
- Ex-Dividend Date
- ―
Financial Position
TMC Life Sciences Bhd. as a current ratio of 1.69, with Debt / Equity ratio of 16.75%
- Current Ratio
- 1.69
- Quick Ratio
- 1.51
- Debt to Market Cap
- 0.18
- Net Debt to EBITDA
- 0.75
- Interest Coverage Ratio
- 3.68
Taxes
In the past 12 months, TMC Life Sciences Bhd. has paid 8.36M in taxes.
- Income Tax
- 8.36M
- Effective Tax Rate
- 0.32
Enterprise Valuation
TMC Life Sciences Bhd. EV to EBITDA ratio is 11.28, with an EV/FCF ratio of 17.50.
- EV to Sales
- 1.98
- EV to EBITDA
- 11.28
- EV to Free Cash Flow
- 17.50
- EV to Operating Cash Flow
- 13.19
Balance Sheet
TMC Life Sciences Bhd. has MYR 111.64M in cash and marketable securities with MYR 145.22M in debt, giving a net cash position of -MYR 33.58M billion.
- Cash & Marketable Securities
- MYR 111.64M
- Total Debt
- MYR 145.22M
- Net Cash
- -MYR 33.58M
- Net Cash Per Share
- -MYR 0.02
- Tangible Book Value Per Share
- MYR 0.39
Margins
Gross margin is 44.42%, with operating margin of 7.74%, and net profit margin of 4.42%.
- Gross Margin
- 44.42%
- Operating Margin
- 7.74%
- Pretax Margin
- 6.55%
- Net Profit Margin
- 4.42%
- EBITDA Margin
- 17.59%
- EBIT Margin
- 8.10%
Analyst Forecast
The average price target for TMC Life Sciences Bhd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 13.74%
- EPS Growth Forecast
- 376.19%
